Could cutting certain carbs calm your IBS? new study says yes
NCT ID NCT07299305
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a low-FODMAP diet—which limits certain carbohydrates that can cause gas and bloating—can reduce symptoms and improve quality of life in people with irritable bowel syndrome (IBS). 183 adults with IBS were split into two groups: one received education on the diet, the other did not. Researchers tracked symptom severity and quality of life over six months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- low-FODMAP diet
- What this could lead to
- If it works, this diet could offer a simple, drug-free way to reduce abdominal pain and improve daily life for people with IBS.
- What could go wrong
- This is a completed trial, but results are not yet published. The diet is restrictive and may be hard to follow long-term. It may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
183 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Oct 2025
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * newly diagnosed with IBS based on Rome IV criteria and subtypes of IBS included constipation-predominant, diarrhea predominant, mixed, and unspecified, * aged 18 to 60 years old of both genders, * after taking their consent to participate Exclusion Criteria: * Patients who previously diagnosed with GI comorbidities (such as inflammatory bowel disease, celiac disease, lactose malabsorption, significant diverticular disease, or a history of bowel resection) * Clinically significant systemic disease * pregnant or lactating * drug abuse * serious psychiatric diseases * eating disorders * Presence of blood or pus in stool analysis * Individuals with IBS-alarming symptoms as (did not have a normal colonoscopy)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Irritable bowel disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zagazig University outpatients clinics
Zagazig, Egypt, 44519, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.